5.10% p.a. Early Redemption Worst of GOAL

Underlying: Biogen / Novo Nordisk / Takeda Pharmaceutical SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 41051278 / ISIN: CH0410512781

Last update 20.01.2020
  • Bid

    101.47 %
    Volume: --

  • Ask

    102.47 %
    Volume: --

CurrencyEUR
IssuerUBS AG, London Branch
Settlementphysical
Fixing date09.04.2018
Expiry14.04.2020
Sideways return-- / --
Unit price1'000.00 EUR
Underlying price1)
Biogen
Novo Nordisk
Takeda Pharmaceutical

285.50 USD
-- DKK
-- JPY
Display
  • Product chart
1) Prices are 15 Min. delayed